Panelists ask whether cancer care will shift toward home-administered infusions as payers push for change. Other topics in this forward-looking session include new delivery tech and practice-led solutions.
News|Articles|July 8, 2025
Practical Considerations for AI in Community Oncology
Author(s)Mary Caffrey
Fact checked by: Laura Joszt, MA
Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Advertisement
Advertisement
Can artificial intelligence (AI) really make life better for an oncologist in day-to-day practice? Questions about AI accuracy, how to adopt technology, and who pays are consequential, given the disappointment that practices experienced with the rise of electronic health records (EHRs).
Related to this article
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in health care.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
Michael Mina, MD, PhD, explains Invivyd's accelerated approval path for VYD2311 and how it could change the timing of COVID-19 protection.
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Advertisement
Advertisement